000 01435 a2200361 4500
005 20250516001502.0
264 0 _c20120118
008 201201s 0 0 eng d
022 _a1618-7601
024 7 _a10.1007/s10198-010-0271-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMoreno-Torres, Iván
245 0 0 _aThe impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain.
_h[electronic resource]
260 _bThe European journal of health economics : HEPAC : health economics in prevention and care
_cDec 2011
300 _a563-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCost Control
_xeconomics
650 0 4 _aDrug Costs
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aDrug Prescriptions
_xeconomics
650 0 4 _aEconomics, Pharmaceutical
650 0 4 _aGovernment Regulation
650 0 4 _aHealth Expenditures
_xlegislation & jurisprudence
650 0 4 _aHealth Policy
650 0 4 _aHumans
650 0 4 _aPharmaceutical Preparations
_xeconomics
650 0 4 _aPublic Health
650 0 4 _aSpain
700 1 _aPuig-Junoy, Jaume
700 1 _aRaya, Josep M
773 0 _tThe European journal of health economics : HEPAC : health economics in prevention and care
_gvol. 12
_gno. 6
_gp. 563-73
856 4 0 _uhttps://doi.org/10.1007/s10198-010-0271-1
_zAvailable from publisher's website
999 _c20142409
_d20142409